Unaudited Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Operating expenses:
Research and development expense	$ 13,684	$ 16,198	$ 26,039	$ 35,050
General and administrative expense	4,963	5,774	10,222	11,379
Total operating expenses	18,647	21,972	36,261	46,429
Loss from operations	(18,647)	(21,972)	(36,261)	(46,429)
Other income (loss):
Interest income	233	900	633	2,123
Gain (loss) on warrant liability	(297)	0	1,583	0
Total other income (loss)	(64)	900	2,216	2,123
Net loss and comprehensive loss	$ (18,711)	$ (21,072)	$ (34,045)	$ (44,306)
Net loss per common share, basic	$ (0.32)	$ (0.44)	$ (0.58)	$ (0.92)
Net loss per common share, diluted	$ (0.32)	$ (0.44)	$ (0.58)	$ (0.92)
Weighted-average shares of common stock outstanding, basic	58,504,396	48,214,893	58,377,516	48,151,176
Weighted-average shares of common stock outstanding, diluted	58,504,396	48,214,893	58,377,516	48,151,176